CN114835784B - 抗炎肽及其用途 - Google Patents

抗炎肽及其用途 Download PDF

Info

Publication number
CN114835784B
CN114835784B CN202111590603.8A CN202111590603A CN114835784B CN 114835784 B CN114835784 B CN 114835784B CN 202111590603 A CN202111590603 A CN 202111590603A CN 114835784 B CN114835784 B CN 114835784B
Authority
CN
China
Prior art keywords
leu
glu
gln
asn
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111590603.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN114835784A (zh
Inventor
N·哈尔迪
C·洛佩兹
A·阿德勒夫欧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP15177013.8A external-priority patent/EP3118215A1/en
Priority claimed from EP15177017.9A external-priority patent/EP3118216A1/en
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Publication of CN114835784A publication Critical patent/CN114835784A/zh
Application granted granted Critical
Publication of CN114835784B publication Critical patent/CN114835784B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Immunology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
CN202111590603.8A 2015-07-16 2016-07-18 抗炎肽及其用途 Active CN114835784B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP15177017.9 2015-07-16
EP15177013.8A EP3118215A1 (en) 2015-07-16 2015-07-16 Anti-inflammatory peptides, and uses thereof
EP15177013.8 2015-07-16
EP15177017.9A EP3118216A1 (en) 2015-07-16 2015-07-16 Cellular growth and proliferation promoting peptides, and uses thereof
CN201680051932.6A CN108348568B (zh) 2015-07-16 2016-07-18 抗炎肽及其用途
PCT/EP2016/067090 WO2017009484A1 (en) 2015-07-16 2016-07-18 Anti-inflammatory peptides, and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680051932.6A Division CN108348568B (zh) 2015-07-16 2016-07-18 抗炎肽及其用途

Publications (2)

Publication Number Publication Date
CN114835784A CN114835784A (zh) 2022-08-02
CN114835784B true CN114835784B (zh) 2025-06-13

Family

ID=56686757

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202111590603.8A Active CN114835784B (zh) 2015-07-16 2016-07-18 抗炎肽及其用途
CN201680051932.6A Active CN108348568B (zh) 2015-07-16 2016-07-18 抗炎肽及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680051932.6A Active CN108348568B (zh) 2015-07-16 2016-07-18 抗炎肽及其用途

Country Status (12)

Country Link
US (4) US10463591B2 (enExample)
EP (3) EP3747425A1 (enExample)
JP (3) JP2018523703A (enExample)
KR (3) KR102576571B1 (enExample)
CN (2) CN114835784B (enExample)
AU (2) AU2016293129B2 (enExample)
BR (1) BR112018000660A2 (enExample)
CA (1) CA2992378A1 (enExample)
DK (1) DK3322430T3 (enExample)
ES (1) ES2806989T3 (enExample)
MX (2) MX377692B (enExample)
WO (1) WO2017009484A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4129321B1 (en) * 2016-12-05 2025-10-15 Nuritas Limited Compositions comprising peptide wkdeagkplvk
JP7340314B2 (ja) * 2020-01-15 2023-09-07 Tdk株式会社 米に含まれるタンパク質の含有量を測定する方法
KR102354916B1 (ko) * 2020-02-11 2022-01-26 주식회사 쓰리빅스 신규 펩타이드 3ps_i014 및 이의 용도
FR3114744B1 (fr) 2020-10-02 2024-01-05 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l’apparence des phanères
US20240043474A1 (en) * 2020-12-16 2024-02-08 Ajou University Industry-Academic Cooperation Foundation Anti-inflammatory peptide for preventing or treating atopic dermatitis
CN114478702B (zh) * 2022-04-06 2023-12-12 中南林业科技大学 一种米糠来源短肽及其在治疗皮肤损伤中的应用
CN116375828B (zh) * 2022-09-08 2024-06-04 浙江大学 一种具有抗菌活性的抗菌肽kta及其应用
CN116253782B (zh) * 2022-09-08 2024-06-04 浙江大学 一种广谱抗菌肽ktr及其应用
FR3141066A1 (fr) * 2022-10-24 2024-04-26 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer la matrice extracellulaire du derme de la peau et/ou des muqueuses
CN116491631B (zh) * 2023-05-26 2024-06-25 青岛农业大学 一种预制菜红烧肉及其制备方法
WO2024259556A1 (en) * 2023-06-19 2024-12-26 Viage Therapeutics, Inc. Uses of therapeutic peptides
CN118812660A (zh) * 2023-06-29 2024-10-22 长沙理工大学 一种米渣蛋白源免疫抑制肽及其应用
WO2025133189A1 (en) * 2023-12-20 2025-06-26 Nuritas Limited Sleep promoting peptides and the use thereof
CN117986337B (zh) * 2024-02-02 2024-08-16 杭州御寿生物科技有限公司 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用
CN120574921A (zh) * 2025-08-06 2025-09-02 浙江诺衍生物科技有限公司 一种有助于降血糖的大米肽及其应用
CN120590476A (zh) * 2025-08-06 2025-09-05 浙江诺衍生物科技有限公司 一种有助于降血糖的七肽及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101917866A (zh) * 2007-04-16 2010-12-15 索莱有限责任公司 具有改善的感官特性和物理特性的蛋白质水解产物组合物
WO2014127798A1 (en) * 2013-02-19 2014-08-28 Danone, S.A. Functional peptides for obesity disorders

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
CA2104595A1 (en) 1991-03-07 1992-09-08 Svend Eriksen Pea protein hydrolyzate, method for production thereof and use thereof
US5516642A (en) 1992-11-16 1996-05-14 Bristol-Myers Squibb Company Polypeptides derived from major histocompatibility complex Class I antigen
JP2673659B2 (ja) 1994-02-11 1997-11-05 株式会社ホーネンコーポレーション ペプチド
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
IT1313572B1 (it) 1999-07-27 2002-09-09 Enichem Spa Procedimento per la preparazione di epossidi.
US20110131679A2 (en) 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
JP2001335596A (ja) 2000-05-24 2001-12-04 Kenji Sakamoto 新規ペプチド及びその医薬用途
CA2444524A1 (en) 2001-04-17 2002-10-24 Ista, S.P.A. Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
AU2003290582A1 (en) * 2002-11-04 2004-06-07 Florida State University Research Foundation NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale)
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
CN1832755A (zh) 2003-05-23 2006-09-13 佩斯特卡生物医疗实验室公司 使用干扰素治疗严重急性呼吸综合征及其他病毒感染
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US20070053845A1 (en) 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
AU2006263332B2 (en) 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
US8105572B2 (en) 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
KR100759495B1 (ko) 2006-02-17 2007-09-18 재단법인서울대학교산학협력재단 친수성 생리활성 펩타이드와 소수성 물질을 포함한자기조립 나노구조체
JP5645360B2 (ja) 2006-04-21 2014-12-24 株式会社明治 ジペプチドを有効成分として含有する組成物
ES2716864T3 (es) 2007-06-06 2019-06-17 Monsanto Technology Llc Genes y usos para la mejora de plantas
CN101835799A (zh) * 2007-08-24 2010-09-15 麦莱克萨有限公司 超敏反应调节剂
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
JP5729297B2 (ja) * 2009-07-13 2015-06-03 不二製油株式会社 経口性抗炎症剤及び経口性抗炎症ペプチド
WO2011122937A1 (en) 2010-03-29 2011-10-06 N.V. Nutricia Pea protein peptides with anti helicobacter pylori activity
ES2397890B1 (es) 2011-03-25 2014-02-07 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
EP2793605A1 (en) * 2011-12-21 2014-10-29 Laboratorios Ordesa, S.L Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity
AU2013308409A1 (en) 2012-08-31 2015-03-26 University Of Birmingham Target peptides for immunotherapy and diagnostics
KR20230125097A (ko) 2014-12-04 2023-08-28 마리 케이 인코포레이티드 트리플루오로아세틸 트리펩타이드-2를 포함하는 국소피부 케어 조성물
US20170183386A1 (en) 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101917866A (zh) * 2007-04-16 2010-12-15 索莱有限责任公司 具有改善的感官特性和物理特性的蛋白质水解产物组合物
WO2014127798A1 (en) * 2013-02-19 2014-08-28 Danone, S.A. Functional peptides for obesity disorders

Also Published As

Publication number Publication date
WO2017009484A1 (en) 2017-01-19
MX2020010806A (es) 2020-10-28
CN108348568A (zh) 2018-07-31
US20200060956A1 (en) 2020-02-27
US20240238184A1 (en) 2024-07-18
AU2016293129A1 (en) 2018-02-01
US20220233425A1 (en) 2022-07-28
JP7739355B2 (ja) 2025-09-16
AU2016293129B2 (en) 2021-01-28
EP3322430A1 (en) 2018-05-23
EP3954700A1 (en) 2022-02-16
KR102307260B1 (ko) 2021-10-01
US10463591B2 (en) 2019-11-05
CN108348568B (zh) 2021-12-28
DK3322430T3 (da) 2020-06-29
CN114835784A (zh) 2022-08-02
US20190029939A1 (en) 2019-01-31
EP3322430B1 (en) 2020-03-25
JP2018523703A (ja) 2018-08-23
JP2023109950A (ja) 2023-08-08
CA2992378A1 (en) 2017-01-19
US11253456B2 (en) 2022-02-22
AU2021202423A1 (en) 2021-05-13
ES2806989T3 (es) 2021-02-19
MX2018000697A (es) 2018-08-15
JP2022009415A (ja) 2022-01-14
KR102576571B1 (ko) 2023-09-11
KR20180029237A (ko) 2018-03-20
EP3747425A1 (en) 2020-12-09
US11779531B2 (en) 2023-10-10
BR112018000660A2 (pt) 2019-05-14
JP7288026B2 (ja) 2023-06-06
KR20230132623A (ko) 2023-09-15
MX377692B (es) 2025-03-10
KR20210120134A (ko) 2021-10-06

Similar Documents

Publication Publication Date Title
CN114835784B (zh) 抗炎肽及其用途
CN114907464A (zh) 用于促进葡萄糖转运的肽
AU2024211009A1 (en) Growth promoting peptides, and uses thereof
HK40069687A (en) Anti-inflammatory peptides derived from rice proteins (oryza sativa) and uses thereof
HK40061519A (en) Growth promoting peptides and uses thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20240410

Address after: lyon

Applicant after: BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S.

Country or region after: France

Address before: Ai Erlandubailin

Applicant before: NURITAS Ltd.

Country or region before: Ireland

GR01 Patent grant
GR01 Patent grant